Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Apr;56(4):929-30.
doi: 10.1007/s10620-011-1578-1.

Testing beneficial therapy in human cirrhosis using animal models of cirrhosis

John Carl Hoefs, Timothy Morgan, Bernard Joseph Ilagan
Editorial

Testing beneficial therapy in human cirrhosis using animal models of cirrhosis

John Carl Hoefs et al. Dig Dis Sci. 2011 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Minuk GY, Hawkins K, Kaita K, et al. Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations. Dig Dis Sci. 2010 (Epub ahead of print). doi:10.1007/s10620-010-1456-2. - PubMed
    1. Zhang M, Guopei S, Minuk G. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat. Gastroenterology. 1996;110:1150–1155. doi: 10.1053/gast.1996.v110.pm8613004. - DOI - PubMed
    1. Kaita K, Assy N, Gauthier T, Zhang M, Meyers A, Minuk G. The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure. Hepatology. 1998;27:533–536. doi: 10.1002/hep.510270230. - DOI - PubMed
    1. Minuk G, Gauthier T, Zhang X, Wang G, Burczynski F. Ciprofloxacin prevents the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat. Hepatology. 1995;22:1797–1800. - PubMed
    1. Everson GT, Shiffman ML, Morgan TR, et al. The spectrum of hepatic functional impairment in patients with fibrosis and compensated cirrhosis due to chronic hepatitis c: results from the HALT-C Trial. Aliment Pharmacol Ther. 2008;27:798–809. doi: 10.1111/j.1365-2036.2008.03639.x. - DOI - PubMed

Substances